Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and nine months ended September 30, 2025
Filing Date: November 13, 2025
Principal Office: Vancouver, British Columbia, Canada
This filing serves as a cover document submitting unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis (MD&A) for the period ended September 30, 2025. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The following metrics are referenced as being included in the attached exhibits but are not detailed in this text:
- Revenue, Profit, and Margins: Not provided in the cover text; see Exhibit 99.1 and 99.2.
- Cash Flow and Liquidity: Not provided in the cover text; see Exhibit 99.1 and 99.2.
- Debt: Not provided in the cover text; see Exhibit 99.1 and 99.2.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. Investors must refer to the attached "Unaudited Interim Condensed Consolidated Financial Statements" (Exhibit 99.1) and "Management's Discussion and Analysis" (Exhibit 99.2) for comparative data.
Guidance, Outlook, and Risks
Specific guidance, management commentary, risk factors, contingencies, or unusual items are not disclosed in the cover document. These disclosures are contained within the attached MD&A (Exhibit 99.2).
Investor Verification Checklist
- Review Exhibit 99.1 for the actual unaudited financial figures for the three and nine months ended September 30, 2025.
- Consult Exhibit 99.2 for management's analysis of financial results, liquidity, and capital resources.
- Verify the certifications provided by the CEO and CFO in Exhibits 99.3 and 99.4 (Form 52-109F2).
- Confirm the company's status as a foreign private issuer filing under Form 40-F.